Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction–Associated Fatty Liver Disease Patients Referred From Primary Care

Zhengyi Wang,Luis Calzadilla Bertot,Gary P Jeffrey,John Joseph,George Garas,Bastiaan de Boer,Yi Huang,Gerry MacQuillan,Michael Wallace,Briohny Smith,Leon A Adams

Clinical Gastroenterology and Hepatology（2022）

引用 7|浏览16

暂无评分

摘要

Serum NIT's accurately stratify risk of liver-related outcomes in MAFLD patients and can be used as a screening tool for patients referred for specialist review by primary care.

查看译文

关键词

Noninvasive Testing,Outcomes,Hepascore,FIB-4,Cirrhosis,NAFLD,Hepatocellular Carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要